NR 503 Week 6 Assignment: Epidemiological Analysis of a Chronic Health Problem

Chamberlain University | College of Nursing | NR-503: Population Health, Epidemiology and Statistical Principles | Master of Science in Nursing | Fall Session 2026

Assessment type: one scholarly paper in eight prescribed sections, with a student-built table. Length: 7 to 10 pages, excluding the title page and the reference list. Format: APA style, current edition, double spaced, with a reference list. Weight: 200 points, of which 185 sit in content and 15 in format. Submission: the dropbox, end of Week 6. The disease topic rotates between sessions, so confirm your assigned condition against the course announcement before you write a word.

Assessment Context

Chamberlain University runs NR-503 Population Health, Epidemiology and Statistical Principles as a core course in the Master of Science in Nursing, and the Week 6 Epidemiological Analysis of a Chronic Health Problem is the paper where descriptive epidemiology, surveillance practice, and screening statistics stop being abstractions. The paper asks a graduate nurse to take one chronic condition, locate it in a real state and county, trace how it is counted, then convert the whole analysis into a plan of action a nurse practitioner could carry into practice. Faculty grade section compliance first, because the eight sections are prescribed and a missing one is visible from the first page.

What separates a strong submission from an adequate one is not length. A 7-page paper that answers every section with state-specific numbers beats a 10-page paper of national statistics copied from a fact sheet. Build the analysis around your own geography and the arithmetic follows.

Source note. A published course export for this assignment still cites APA sixth edition, and archived rubric copies list the rotating topics as hypertension, type 1 diabetes, cystic fibrosis, and macular degeneration. Current sections use APA seventh edition and rotate topics per session. Confirm both in your classroom.

Where the Points Sit

The rubric splits 200 points across eight content rows and a small format block. Content carries 185 points at 92 percent. Grammar, syntax, and spelling carry 5 points at 3 percent. APA formatting carries the remaining 10 points at 4 percent. Two rows carry more weight than the rest, the descriptive epidemiological analysis at 35 points and three separate rows at 30 points each.

Rubric row	Points	Share
Identification of the health problem	15	7.5 percent
Background and significance, including the student-built table	30	15 percent
Current surveillance and reporting methods	30	15 percent
Descriptive epidemiological analysis, all five W’s	35	17 percent
Screening, diagnosis, and guidelines	30	15 percent
Plan of action	30	15 percent
Summary and conclusion	15	7.5 percent
Grammar, syntax, spelling	5	3 percent
APA formatting	10	4 percent
Total	200	100 percent

Read that table before outlining. Three rows at 30 points each reward the same habit, which is naming a specific mechanism and then citing the body that operates it. The screening row at 30 points rewards arithmetic, not adjectives.

Picking the Condition

Work only with the condition your section assigns. Where a choice exists, hypertension is the friendliest topic because the data infrastructure is mature and the screening literature is dated and citable. Hypertension also carries a documented national cost burden and an established federal recommendation, so every section has something traceable to say.

Type 1 diabetes and cystic fibrosis present a harder problem, since state-level prevalence for a low-prevalence condition may not exist in a usable form. When that happens, do not manufacture a figure. State the gap, name the surveillance system that should hold it, and convert the gap into the first item of your plan. The rubric language for the background row rewards an honest account of the data situation more than a fabricated table.

Section by Section Requirements

Opening Section

No heading for the introduction under APA style, and no abstract. Open with the problem, why it matters to the population you will serve, and a one-paragraph map of what follows. Keep it to about half a page. A reader should finish it knowing which condition, which state, and which three or four claims the paper will defend.

Background and Significance

Cover definition, clinical description, signs and symptoms, then incidence or prevalence in your state against the national figure. Build the table yourself. Copying a table from a source and pasting it in fails the requirement even when the numbers are correct, because the row labelled in the rubric asks for a table you constructed.

Table element	What to put there	Where the numbers come from
Geography rows	County or city, state, national	State health department epidemiology report, BRFSS state prevalence data, national survey or statistical update
Measure columns	Prevalence percent, and incidence per 100,000 where published	Label the year of each estimate in the column header
Comparison column	State against national, as a ratio or percentage point difference	Compute it yourself and show the arithmetic in the note
Table note	Definitions, denominators, and the year of collection	APA table note below the table, not inside it

Watch the denominators. A state prevalence percentage and a national age-adjusted rate cannot be subtracted from one another, and mixing them produces a comparison that collapses under scrutiny. State which measure each row uses and keep the measures parallel within a table.

Surveillance and Reporting

Name the system, not just the agency. For hypertension, the relevant streams include the national risk factor surveillance survey, vital statistics mortality files, and the state-level epidemiology publications built from them. Then answer the reporting question directly. Hypertension is a diagnosis, not a reportable condition, so the mandated reporting pathway that exists for communicable disease does not apply here, and saying so is the correct answer rather than a gap. Hospital discharge datasets and death certificate coding carry the burden instead. A student who writes that hypertension is not on the reportable list, then explains what fills the vacuum, has answered the row properly.

Descriptive Epidemiology

Five W’s, each with a citation and each with detail specific to your geography. This row carries the most points of any single item, so it earns the most words.

1. What. The condition as defined for epidemiological purposes, with the diagnostic threshold you are using and the coding convention where it matters.
2. Who. Distribution by age, sex, race and ethnicity, and the determinants of health that shape that distribution, including income, insurance, food access, and neighbourhood conditions.
3. Where. Geographic concentration, with your county or region placed against the state figure rather than against a country-level average.
4. When. Trend across a defined period, stated with the years, and a note on whether the trend reflects changing incidence or changing detection.
5. Why. The causal web, kept explicit about what is established and what is plausible.

Then add cost. The rubric asks for financial and social cost, and most submissions give only the financial half. Social cost includes lost productivity, caregiving burden, transportation, and premature mortality. A federal cost estimate belongs in the financial sentence, with the source and year attached, because cost figures age badly and an undated figure reads as carelessness.

Screening and Diagnosis

State the national recommendation and its grade, then take one screening test and dissect it through sensitivity, specificity, predictive value, reliability, and cost. The rubric asks for validity and predictive value explicitly. A test described as accurate without a number does not satisfy the row. The section below shows how to make the arithmetic visible.

Plan of Action

Three interventions, each tied to a level of prevention and each with a measurement. Primary, secondary, and tertiary prevention gives you a defensible structure, and so does a split across the clinic, the health system, and the policy environment. Every intervention needs a citation that connects to an actual study or guideline, and every measurement needs a numerator, a denominator, and a review interval.

Intervention	Prevention level	How to measure it
Standardised in-clinic measurement technique with repeat readings before any new diagnosis	Secondary	Proportion of newly diagnosed patients with two elevated readings on separate occasions, reviewed monthly
Self-measured blood pressure with clinician support and structured follow-up	Secondary and tertiary	Proportion of enrolled patients submitting at least one weekly reading, and change in mean systolic pressure at six months
Community screening and referral linkage in a food or pharmacy setting	Primary and secondary	Proportion of positive screens that complete a diagnostic visit within 30 days

Add a short policy strand, such as reimbursement for self-measured monitoring or pharmacist-led titration authority, and the plan answers the rubric line about policy advocacy without a separate section.

Summary

One paragraph per section, in order, no new claims. The rubric asks for a brief overview of key points with integration of resources, which means citations can appear here without discomfort. Do not restate the introduction and call it a conclusion.

Making Screening Arithmetic Visible

Validity and predictive value are the two terms most often misused in this section. Sensitivity is the share of truly hypertensive people the test flags. Specificity is the share of truly normotensive people the test clears. Predictive value depends on how common the condition is in the room you are standing in, which is why the same test performs differently in a community fair and in a nephrology clinic.

Work the arithmetic with published estimates. The federal evidence review behind the current recommendation pooled fifteen studies and reported office measurement at a threshold of 140/90 against ambulatory monitoring, giving a sensitivity of 0.54 and a specificity of 0.90. Take 1,000 adults in a primary care panel with no recorded hypertension diagnosis and assume 250 have it, a conservative figure that keeps the illustration on the safe side of national awareness data.

Outcome	Count per 1,000 screened	Derivation
True positive	135	250 multiplied by 0.54
False negative	115	250 minus 135
False positive	75	750 multiplied by 0.10
True negative	675	750 minus 75
Positive predictive value	64.3 percent	135 divided by 210
Negative predictive value	85.4 percent	675 divided by 790

The teaching point writes itself. Roughly one in three positive screens is a false positive at this prevalence, and 115 true cases slip through. That is exactly why the recommendation pairs an office reading with out-of-office confirmation before treatment starts, and a paper that shows the arithmetic explains the guideline better than a paper that quotes it.

Length, Format, and Submission

• 7 to 10 pages, excluding title page and references. Faculty may return the paper for trimming or deduct up to five points, but not both.
• APA seventh edition, double spaced, one-inch margins, page numbers in the header, headings at the prescribed levels.
• At least one table you built. Include the table number, a descriptive title in italics, and a note beneath.
• Scholarly in-text citations throughout, with a reference list that matches them one for one. Sources older than five years need justification or instructor approval in most Chamberlain sections.
• Check the draft through the originality tool before submission. Confirm the dropbox accepted the file type.

Marking Rubric

Criterion	Points	What earns full credit
Identification of the health problem	15	Problem stated precisely with significance and a map of the paper’s content
Background and significance	30	Definition, symptoms, risks, impact, and state against national data, supported by a table the student constructed
Surveillance and reporting	30	Named systems, the statistics they collect, and an explicit answer on reportable status
Descriptive epidemiological analysis	35	All five W’s developed, determinants of health analysed, financial and social costs included
Screening, diagnosis, guidelines	30	Current national standards plus sensitivity, specificity, predictive value, reliability, and cost for one test
Plan of action	30	Three evidence-based interventions with prevention levels, citations, and measurable outcomes
Summary and conclusion	15	Key points from every section, integrated, no new claims
Grammar, syntax, spelling	5	No errors that interfere with reading
APA formatting	10	Consistent seventh edition across title page, headings, citations, references, and tables

Academic Integrity and Source Verification

• Chamberlain applies its academic integrity policy to this paper, and the dropbox runs an originality review.
• Do not recycle a paper written for another course or another condition, even your own. Self-plagiarism is treated the same as any other form.
• Open every source. Confirm authors, year, journal, volume, issue, pages, and DOI, then confirm the claim appears in the source where you place it.
• State any assumption you make about missing data in one sentence and move on. An assumption disclosed is scholarship; an assumption concealed is a citation problem waiting to be found.

References and Learning Materials

Jones, D. W., Ferdinand, K. C., Taler, S. J., & Writing Committee Members. (2025). 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults. Circulation, 152(11), e114–e218. https://doi.org/10.1161/CIR.0000000000001356

Kirkland, E. B., Heincelman, M., Bishu, K. G., Schumann, S. O., Schreiner, A., Axon, R. N., Mauldin, P. D., & Moran, W. P. (2018). Trends in healthcare expenditures among US adults with hypertension: National estimates, 2003–2014. Journal of the American Heart Association, 7(11), e008731. https://doi.org/10.1161/JAHA.118.008731

Martin, S. S., Aday, A. W., Allen, N. B., Almarzooq, Z. I., Anderson, C. A. M., Arora, P., Avery, C. L., & American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Committee. (2025). 2025 heart disease and stroke statistics: A report of US and global data from the American Heart Association. Circulation, 151, e1–e620. https://doi.org/10.1161/CIR.0000000000001303

US Preventive Services Task Force. (2021). Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA, 325(16), 1650–1656. https://doi.org/10.1001/jama.2021.4987

Sample Response: Building the Comparison Table

The county where I practice sits inside a state whose adult hypertension prevalence tracks close to the national figure, and that similarity is precisely what makes the local story easy to miss. National data put hypertension in roughly 45 percent of United States adults, and the condition accounts for about 131 billion dollars in annual health care expenditure, a figure that has held steady across a twelve-year window rather than falling with better treatment (Kirkland et al., 2018). A state figure that matches the national percentage still hides a county with twice the burden, because prevalence is an average and an average flattens geography. Building the table forced me to compare three geographies on one measure instead of three measures on one geography, which is the difference between a table that argues and a table that decorates. My own county runs above the state figure on the state health department estimate, and the gap appears in the age band from 45 to 64, which is the band where undiagnosed cases concentrate. That single observation reshaped the plan section, since a working-age population with elevated prevalence points toward employer and pharmacy settings rather than a geriatric clinic. State your denominators in the table note and the reader trusts the comparison. Hide them and the comparison looks like arithmetic done in the dark.

Sample Response: Five W’s Without a Checklist

Descriptive epidemiology reads as a checklist when each W is answered in a separate sentence with no connection to the next, so I sequenced mine as a causal argument instead. For the who, national surveillance shows hypertension burden landing unevenly across racial and ethnic groups, and the disparities follow differences in access, diet, stress, and treatment intensity rather than biology alone, which is why the 2025 heart disease and stroke statistics report from the American Heart Association treats them as population patterns rather than individual risk factors (Martin et al., 2025). The where followed from the who, since the county tracts with the highest share of uninsured working-age adults also carry the highest emergency department rates for hypertensive crisis. For the when, the trend over the last decade looks flat in prevalence but rising in complication rates, and that divergence suggests detection is not keeping pace with disease rather than the disease accelerating. Cost entered as two sentences, one naming the federal expenditure estimate and one naming the social side, which for this population means lost workdays and caregiving. Answering the why honestly required hedging, since the causal web around hypertension is well described for some pathways and speculative for others, and saying which is which reads as command of the material. Sequence the five W’s as a chain and the section stops feeling like a form.

Where the Federal Recommendation Lands

The current recommendation assigns an A grade to screening adults aged 18 and older with office blood pressure measurement, then calls for out-of-office confirmation before treatment begins, which is a two-step standard rather than a single test. Read the evidence review behind it and the reason becomes plain, since the pooled analysis of fifteen studies found office measurement carried a sensitivity of 0.54 and a specificity of 0.90 against ambulatory monitoring as the reference standard (screening for hypertension in adults, US Preventive Services Task Force, 2021). Sensitivity near one half sounds like a broken test until you notice what the low figure protects against, which is a cascade of treatment started on a single reading taken in a hurried room. The 2025 clinical guideline reinforces the same architecture, setting a treatment target below 130/80 for most adults while keeping the diagnostic pathway anchored in confirmation rather than in one measurement (Jones et al., 2025). Students often write up the recommendation and stop there, which answers half the rubric row. The other half asks for predictive value and cost, and both require you to do arithmetic rather than quote a sentence. Show the two-by-two counts and the section stops being a summary.

Reading a Borderline Result

A question that shows up in every section of this course concerns what to do with a reading that sits between normal and clearly elevated. The honest answer distinguishes three phenomena that students tend to collapse into one. White coat effect raises pressure in the clinical setting and resolves outside it, masked hypertension does the reverse, and sustained hypertension shows up in both settings, which is why confirmation outside the clinic changes management rather than merely repeating the same number. Reliability belongs in the same paragraph, since a single measurement carries more error than two averaged readings taken with a validated device and a correct cuff size. Cost belongs here too, because ambulatory monitoring costs more per patient than a repeat office visit and the justification rests on avoided overtreatment rather than on the test price alone. Frame the section as a clinical decision problem and every element the rubric names finds a natural home.

1. Define the reference standard first, since sensitivity and specificity mean nothing until the comparator is named.
2. Report the pooled estimates with their confidence intervals, not just the point values.
3. Compute predictive value at a prevalence you can justify for your own setting, and show the counts.
4. Name the harms of a false positive, because the rubric asks for validity and a good answer asks what invalidity costs the patient.

Write it that way and the screening section defends itself without a single adjective about accuracy.

Plan Section Without Bureaucratese

The plan row is where thoughtful papers lose points, and the cause is usually abstraction. An intervention phrased as improving education or increasing awareness cannot be measured, so the outcome row in your table stays empty and the grader has nothing to credit. Replace the abstraction with an action and a count. Standardised measurement technique becomes a written protocol with a repeat reading on a second day, measured as the share of new diagnoses meeting that standard. Self-measured monitoring becomes enrolment with a weekly submission target, measured as the share of enrolled patients submitting at least one reading per week and the change in mean systolic pressure at six months. Community screening becomes a referral pathway with a clock on it, measured as the share of positive screens reaching a diagnostic visit within thirty days. Tie each strand to a prevention level and the structure answers the rubric line about primary, secondary, and tertiary activity without a heading for it. One policy sentence at the end, naming reimbursement or scope authority, covers the advocacy expectation and keeps the section honest about what a single clinician can and cannot change.

Conclusion

I would pick hypertension if my section allows a choice, mostly because the data exist at county level and I would rather argue with real numbers than explain why mine are missing. Building the table before writing the background section changed my outline, since the county-versus-state gap pointed at a working-age population and that pushed the whole plan toward pharmacy and employer settings. The five W’s were the section I expected to be easy and the one that took longest, because the why cannot be written without admitting which parts of the causal story are settled. My screening section got better once I stopped describing the test and started counting false positives. What I would change in a revision is the summary, which repeated the introduction instead of integrating the plan. Ten pages felt long until I mapped the rubric rows onto it and realized the length was the sections, not padding.

Frequently Asked Questions

Can I use a table from a published source

No. The requirement is a table you construct from data you gathered. Reproduce the numbers with a citation, then build your own rows and columns around them.

Do I need county-level figures as well as state figures

Where they exist, yes. Where they do not, state the gap, name the surveillance system that should hold the data, and treat the gap as the first item in your plan.

Which citation edition applies

APA seventh edition in current sections. Archived copies of this assignment still cite the sixth edition, so confirm the edition in your classroom before formatting the title page.

~~~

Epidemiological Analysis of Hypertension in Adults: Population Health, Screening, and Prevention

Chamberlain University | College of Nursing | NR-503: Population Health, Epidemiology and Statistical Principles | Fall 2026

Working assumption: Hypertension is used as the assigned condition because the supplied assessment material develops this topic. The geographical analysis below uses Illinois and Cook County as an illustrative case, not as a claim about the student’s actual practice location. The assigned condition and practice location must match the Week 6 classroom instructions before submission.

Academic paper

Introduction

Hypertension remains a major public health concern in the United States because it increases the risk of cardiovascular disease, stroke, chronic kidney disease, and premature death. The National Center for Health Statistics estimated that 47.7% of American adults had hypertension during August 2021 to August 2023. However, only 59.2% of affected adults knew they had the condition, while 20.7% had achieved blood pressure control below 130/80 mm Hg (Fryar et al., 2024). These findings reveal a gap between disease prevalence, diagnosis, and effective management. Population health nurses and nurse practitioners play an important role in closing that gap through early identification, accurate screening, treatment coordination, and community-based prevention. The epidemiological analysis examines hypertension through its clinical characteristics, population distribution, surveillance methods, screening evidence, and associated costs. It also proposes measurable nursing interventions that address prevention and long-term blood pressure control.

Background and Clinical Description

Hypertension refers to persistently elevated arterial blood pressure, which increases the workload on the heart and damages blood vessels over time. The 2025 American Heart Association and American College of Cardiology guideline retains the clinical importance of early detection and appropriate blood pressure management. Under the established classification, normal blood pressure falls below 120/80 mm Hg, elevated blood pressure ranges from 120–129 mm Hg systolic with diastolic pressure below 80 mm Hg, and stage 1 hypertension begins at 130–139 mm Hg systolic or 80–89 mm Hg diastolic (Jones et al., 2025). Stage 2 hypertension begins at 140 mm Hg systolic or 90 mm Hg diastolic. Diagnosis requires appropriate measurement and clinical assessment rather than reliance on an isolated reading.

Most people with hypertension do not experience noticeable symptoms, particularly during the early stages. Some patients develop headaches, visual disturbances, dizziness, or chest discomfort, although these symptoms do not reliably establish a diagnosis. Persistent elevation may damage the kidneys, heart, retina, and cerebral blood vessels. Primary hypertension accounts for most adult cases and commonly develops through interactions among genetic susceptibility, ageing, excess sodium intake, physical inactivity, obesity, and social conditions. Secondary hypertension develops from identifiable causes such as renal disease, endocrine disorders, or certain medications. The distinction matters because secondary hypertension may require treatment of the underlying condition as well as blood pressure management.

Epidemiological Data and Population Distribution

National figures provide a useful reference point, but local estimates help identify communities that require additional preventive services. Hypertension prevalence depends on the measurement method and diagnostic definition. National Health and Nutrition Examination Survey estimates use measured blood pressure and medication history, whereas CDC PLACES estimates county-level diagnosed hypertension using behavioural surveillance data and statistical modelling. These sources should not be treated as interchangeable.

The following table provides the structure for a valid geographical comparison. The county and state figures require extraction from the same CDC PLACES data release before final submission.

Table 1

Adult Diagnosed Hypertension: National, State, and County Comparison

Note. The national estimate comes from NHANES and reflects measured hypertension. The Illinois and Cook County estimates should come from the same CDC PLACES release and represent diagnosed hypertension among adults. The measures have different definitions and must not be subtracted or interpreted as directly comparable prevalence estimates (Fryar et al., 2024).

The distinction also affects interpretation. A county estimate based on self-reported diagnosis may understate the underlying burden where residents face barriers to screening or primary care. Consequently, low recorded prevalence does not necessarily indicate better population health. Local health departments should combine prevalence estimates with information about insurance coverage, healthcare access, cardiovascular mortality, and emergency visits to identify communities where undiagnosed hypertension may remain common.

Confirmed local data for Table 1: The 2024 Healthy Illinois Survey reports diagnosed hypertension in 39.4% of Illinois adults and 37.5% of Cook County adults. The county estimate is 1.9 percentage points below the state estimate. The same data source reports 37.3% for Cook County and 39.0% for Illinois in 2025, indicating little change over the two-year period. These figures replace the two verification entries in the table. The 47.7% national figure remains a separate NHANES estimate based on measured blood pressure and medication history, so the paper does not treat the measures as directly equivalent.

Surveillance and Reporting

Hypertension surveillance relies on several data systems because the condition does not follow the routine case-reporting pathway used for nationally notifiable infectious diseases. The Behavioral Risk Factor Surveillance System (BRFSS) collects self-reported information about diagnosed hypertension, medication use, and associated risk factors. The National Health and Nutrition Examination Survey (NHANES) adds physical examinations and measured blood pressure, making it useful for estimating undiagnosed disease. CDC PLACES uses statistical methods to provide local estimates, while state health surveys such as the Healthy Illinois Survey offer additional county-level information. Electronic health records, insurance claims, hospital discharge records, and the National Vital Statistics System also contribute information about diagnosis, treatment, complications, and mortality. Illinois requires healthcare providers and laboratories to report specified notifiable diseases through the Illinois Disease Surveillance System, but routine hypertension diagnoses do not fall under that mandatory reporting process. Consequently, population health nurses must interpret survey estimates alongside clinical and administrative records rather than expect a complete hypertension case registry (Sekkarie et al., 2024).

Descriptive Epidemiological Analysis

The five epidemiological questions help explain how hypertension affects the population of Cook County. What refers to persistent blood pressure elevation, generally classified from 130/80 mm Hg under current clinical guidance, with ICD-10-CM code I10 commonly identifying essential hypertension. Who reflects differences across demographic groups. National data indicate higher prevalence among men than women, while non-Hispanic Black adults experience a greater burden than other major racial and ethnic groups. Age also matters: prevalence increases substantially among older adults, and social conditions such as limited insurance, lower income, poor access to healthy food, and restricted opportunities for physical activity may increase the risk of poor control (Jones et al., 2025; Centers for Disease Control and Prevention [CDC], 2026).

Where identifies the geographic concentration of the condition. Cook County’s diagnosed prevalence of 37.5% in 2024 remained below the Illinois estimate of 39.4%, although both figures represent a substantial adult health burden. When considers changes over time. The county estimate moved from 37.5% in 2024 to 37.3% in 2025, while the state estimate changed from 39.4% to 39.0%. Such small changes do not establish a meaningful reduction in disease incidence. Survey participation, access to diagnostic services, and awareness of previous diagnoses may influence self-reported prevalence. Why considers the interaction of biological, behavioural, and social causes. Age, family history, obesity, high sodium intake, physical inactivity, alcohol consumption, tobacco exposure, and chronic stress contribute to risk. Limited primary care access and medication affordability may also delay diagnosis or prevent adequate control.

The racial distribution requires careful interpretation. Higher hypertension rates among Black adults should not become an assumption that race itself causes hypertension. Differences in access to preventive care, neighbourhood resources, chronic stress, income, and treatment quality offer important explanations for unequal outcomes. The same reasoning applies to Cook County, where county-wide averages may conceal disparities between neighbourhoods. Health departments therefore need more detailed local information before directing resources toward particular communities.

Economic and Social Burden

Hypertension places a substantial financial burden on patients, healthcare institutions, and public health systems. Wang et al. (2024) estimated that the condition contributed approximately $219 billion in national healthcare expenditures and 817 million healthcare events in 2019. Their analysis also estimated an additional $2,759 in annual healthcare expenditure per affected adult compared with an adult without hypertension. These costs include inpatient care, outpatient services, prescriptions, and other healthcare use. The social burden extends beyond medical expenditure. Adults with uncontrolled hypertension may experience reduced work capacity, disability, and premature death, while family members may assume unpaid caregiving responsibilities. Transportation difficulties, missed work, and the recurring cost of medication can also make treatment difficult for lower-income households. Early diagnosis and sustained blood pressure control may reduce avoidable complications and the demands those complications place on families and healthcare services.

National Screening Recommendation

The United States Preventive Services Task Force (USPSTF, 2021) assigns an A grade to hypertension screening for adults aged 18 years and older who do not have a previous diagnosis. The recommendation supports initial office blood pressure measurement followed by confirmation outside the clinical setting before clinicians initiate treatment. Ambulatory blood pressure monitoring and validated home monitoring provide options for confirmation. The USPSTF recommends annual screening for adults aged 40 years and older and adults at increased risk. Adults aged 18 to 39 years with normal previous readings and no increased risk may undergo screening every three to five years. The 2025 AHA/ACC guideline provides additional clinical direction for diagnosis, cardiovascular risk assessment, lifestyle management, and medication treatment (Jones et al., 2025).

Screening Test Validity and Predictive Value

Office blood pressure measurement offers an accessible screening method, although its diagnostic accuracy has limitations. The USPSTF evidence review used ambulatory blood pressure monitoring as the reference standard and reported pooled sensitivity of 0.54 (95% CI [0.37, 0.70]) and specificity of 0.90 (95% CI [0.84, 0.95]) across 15 studies involving 11,309 participants. Sensitivity indicates the proportion of people with hypertension whom the screening test identifies, whereas specificity measures the proportion without hypertension whom it correctly classifies. The estimates also require caution because the underlying studies showed substantial clinical and methodological differences. Their office measurement threshold was 140/90 mm Hg, compared with ambulatory reference thresholds of 130/80 mm Hg over 24 hours or 135/85 mm Hg during daytime monitoring. Consequently, the estimates should not be applied uncritically to every modern screening protocol (USPSTF, 2021).

A hypothetical primary care panel demonstrates the importance of predictive value. Assume 1,000 adults have a hypertension prevalence of 25%, which gives 250 affected adults and 750 unaffected adults. Applying the reported sensitivity and specificity produces the following results.

Table 2

Illustrative Results of Office Blood Pressure Screening Among 1,000 Adults

Note. Calculations use sensitivity of 54% and specificity of 90%. The assumed 25% prevalence illustrates predictive value and does not represent the measured prevalence of Cook County.

The positive predictive value equals 135 divided by 210, or 64.3%. The negative predictive value equals 675 divided by 790, or 85.4%. Therefore, approximately 36% of positive results represent false positives, while 115 adults with hypertension receive negative initial screens. These results demonstrate why clinicians should confirm elevated readings outside the office. A false-positive result may expose a patient to unnecessary medication, anxiety, additional appointments, and avoidable expenditure. Conversely, a false-negative result may delay treatment and increase the risk of cardiovascular complications.

Reliability also depends on consistent measurement conditions. Healthcare professionals should use validated devices, correct cuff sizes, an appropriate seated position, and at least five minutes of rest before taking measurements. Repeated readings improve confidence in the result, although ambulatory monitoring remains particularly useful when white coat or masked hypertension is suspected. Office screening has relatively low equipment and staffing requirements, whereas ambulatory monitoring involves additional equipment, patient time, and service costs. The additional expense may be justified when confirmation prevents inappropriate treatment or missed diagnosis (USPSTF, 2021).

Prevention and Population Health Action Plan

A practical nursing intervention should address all three levels of prevention. Primary prevention should target adults without diagnosed hypertension who have elevated risk factors. Community health nurses can coordinate education on sodium reduction, healthy eating, weight management, physical activity, and tobacco avoidance through local clinics, workplaces, and community organisations. The clinic should measure the number of participants completing the programme against the total number enrolled and review participation quarterly. Follow-up blood pressure measurements at six and twelve months can indicate whether participants maintain healthy readings.

Secondary prevention should improve early identification and diagnostic confirmation. Nurses can conduct standardized screening during routine appointments and community health events, then arrange home or ambulatory monitoring for patients with positive results. The programme should calculate the proportion of adults with positive screens who complete confirmatory assessment within 30 days. Monthly reviews can identify referral delays and equipment shortages. Such a process reduces the risk of treating a single elevated reading as a confirmed diagnosis.

Tertiary prevention should focus on patients with diagnosed hypertension who remain above their individualized treatment targets. Nurse practitioners can coordinate follow-up with pharmacists and physicians, assess medication adherence, review home blood pressure records, and address barriers to treatment. The clinic should measure the proportion of enrolled patients who achieve their prescribed blood pressure target within six months, using the total number of enrolled patients with uncontrolled hypertension as the denominator. Quarterly reviews should also assess medication adherence and missed appointments. The 2025 AHA/ACC guideline supports structured treatment, lifestyle changes, and team-based management as important elements of blood pressure care (Jones et al., 2025).

Policy advocacy should support reimbursement for validated home blood pressure monitors and appropriate out-of-office diagnostic services. Nurse practitioners can also advocate for collaborative practice arrangements that allow pharmacists to support medication adjustment within applicable state laws. Such policies may reduce the financial barriers that prevent patients from monitoring blood pressure or maintaining regular treatment.

Summary

Hypertension remains a major population health concern because a substantial proportion of adults live with elevated blood pressure and many fail to achieve adequate control. The Cook County and Illinois estimates demonstrate the value of local surveillance, although survey-based prevalence cannot replace measured clinical data. BRFSS, NHANES, mortality records, and healthcare databases each provide different information about disease burden and outcomes. The USPSTF screening recommendation supports early identification, while its diagnostic accuracy evidence demonstrates the need for out-of-office confirmation. A nursing plan that combines lifestyle prevention, reliable screening, and coordinated treatment can address gaps across the care continuum. Regular measurement of programme participation, diagnostic follow-up, and blood pressure control will help nurse practitioners evaluate whether interventions improve outcomes. Policy support for home monitoring and affordable treatment can further strengthen long-term hypertension management.

References

The following six sources provide the principal clinical guidance, epidemiological evidence, economic analysis, and geographical data for the paper. The 2021 USPSTF recommendation remains relevant to the screening discussion, while the 2025 AHA/ACC guideline supplies the more recent clinical management framework.

1. Community Memorial Foundation. (2026). High blood pressure prevalence: Cook County, Illinois. Healthy Communities Institute. https://cmfdn.thehcn.net/indicators/index/view?indicatorId=253&localeId=662

2. Fryar, C. D., Kit, B. K., Carroll, M. D., & Afful, J. (2024). Hypertension prevalence, awareness, treatment, and control among adults age 18 and older: United States, August 2021–August 2023. National Center for Health Statistics, Data Brief No. 511. https://www.cdc.gov/nchs/products/databriefs/db511.htm

3. Illinois Department of Public Health. (n.d.). Infectious disease reporting. https://dph.illinois.gov/topics-services/diseases-and-conditions/infectious-diseases/infectious-disease-reporting

4. Jones, D. W., Ferdinand, K. C., Taler, S. J., Johnson, H. M., Shimbo, D., Abdalla, M., Altieri, M. M., Bansal, N., Bello, N. A., Bress, A. P., Carter, J., Cohen, J. B., Collins, K. J., Commodore-Mensah, Y., Davis, L. L., Egan, B., Khan, S. S., Lloyd-Jones, D. M., Melnyk, B. M., . . . Williamson, J. D. (2025). 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: A report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation, 152(11), e114–e218. https://doi.org/10.1161/CIR.0000000000001356

5. US Preventive Services Task Force. (2021). Screening for hypertension in adults: US Preventive Services Task Force reaffirmation recommendation statement. JAMA, 325(16), 1650–1656. https://doi.org/10.1001/jama.2021.4987

6. Wang, Y., Lee, J. S., Pollack, L. M., Kumar, A., Honeycutt, S., & Luo, F. (2024). Health care expenditures and use associated with hypertension among U.S. adults. American Journal of Preventive Medicine, 67(6), 820–831. https://doi.org/10.1016/j.amepre.2024.07.005